Targeting glutamate mediated excitotoxicity in huntington’s disease: Neural progenitors and partial glutamate antagonist – Memantine

2011 ◽  
Vol 76 (1) ◽  
pp. 138-140 ◽  
Author(s):  
M. Anitha ◽  
M.S. Nandhu ◽  
T.R. Anju ◽  
P. Jes ◽  
C.S. Paulose
2013 ◽  
Vol 12 (6) ◽  
pp. 787-799 ◽  
Author(s):  
Abdellatif Benraiss ◽  
Michael J. Toner ◽  
Qiwu Xu ◽  
Elodie Bruel-Jungerman ◽  
Eloise H. Rogers ◽  
...  

Neurology ◽  
1995 ◽  
Vol 45 (7) ◽  
pp. 1417-1417
Author(s):  
K. Kieburtz ◽  
M. McDermott ◽  
F. J. Marshall ◽  
A. Feigin ◽  
P. Como ◽  
...  

2021 ◽  
Author(s):  
Dilara Ayyildiz ◽  
Alan Monziani ◽  
Takshashila Tripathi ◽  
Jessica Doering ◽  
Guendalina Bergonzoni ◽  
...  

Alternative splicing (AS) appears to be altered in Huntington's disease (HD), but its significance for early, pre-symptomatic disease stages has not been inspected. Here, taking advantage of Htt CAG knock-in mouse in vitro and in vivo models, we demonstrate a strong correlation between Htt CAG repeat length and increased aberrant linear AS, specifically affecting neural progenitors and, in vivo, the striatum prior to overt behavioral phenotypes stages. Remarkably, expanded Htt CAG repeats reflect on a previously neglected, global impairment of back-splicing, leading to decreased circular RNAs production in neural progenitors. Though the mechanisms of this dysregulation remain uncertain, our study unveils network of transcriptionally altered micro-RNAs and RNA-binding proteins (CELF, hnRNPS, PTBP, SRSF) which, in turn, might influence the AS machinery, primarily in neural cells. We suggest that this unbalanced expression of linear and circular RNAs might result in altered neural fitness, contributing to HD striatal vulnerability.


Sign in / Sign up

Export Citation Format

Share Document